|
Volume 270,
Number 46,
Issue of November 17, 1995 pp. 27629-27633
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Identification
of Proximal Sequence Element Nucleotides Contributing to the
Differential Expression of Variant U4 Small Nuclear RNA Genes (*)
(Received for publication, July 31, 1995)
Hirdeypal S.
Bhathal (§),
,
Zulkeflie
Zamrod (¶),
,
Takaaki
Tobaru
,
William
E.
Stumph (**)
From the Department of Chemistry and Molecular Biology
Institute, San Diego State University, San Diego, California 92182-1030
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
ABSTRACT
The two U4 genes in the chicken genome code for distinct
sequence variants of U4 small nuclear RNA that are differentially
expressed during development. Whereas U4B RNA is constitutively
expressed, U4X RNA is specifically down-regulated relative to U4B in a
tissue-specific manner during development. To investigate mechanisms
controlling the differential expression of the U4B and U4X genes,
chimeric U4 genes were constructed and their transcriptional activities
assayed by injection into Xenopus oocytes or by transfection
of CV-1 cells. The proximal regulatory region of the U4B gene and the
enhancers of both the U4B and U4X genes functioned efficiently in each
expression system. However, the proximal region of the U4X gene was
inactive. To localize and identify the responsible nucleotides,
reciprocal point mutations were introduced into the U4X and U4B
proximal regulatory regions. The results indicate that the U4X gene
contains a suboptimal proximal sequence element, and that this results
primarily from the identities of the nucleotides at positions -61
and -57 relative to the transcription start site.
INTRODUCTION
The small nuclear RNAs (snRNAs) ( )of the U family
(U1, U2, U3, etc.) are evolutionarily conserved and metabolically
stable RNAs that function in pre-mRNA and pre-rRNA processing in the
nuclei of eukaryotic cells. The genes for vertebrate snRNAs possess
similar promoter structures and, with the exception of U6, are
transcribed by RNA polymerase II. Two distinct evolutionarily conserved
regions in the 5`-flanking DNA contribute to the expression of
vertebrate snRNA genes(1, 2, 3, 4) .
The more distal region, generally positioned between nucleotides
-250 and -180 relative to the transcription start site,
functions as a transcriptional enhancer. It normally contains at least
one copy of the octamer motif (recognized by the Oct-1 transcription
factor), and it usually contains functional binding sites for one or
more additional proteins, such as a GC box, SPH motif, CCAAT box,
cyclic AMP response element,
etc.(5, 6, 7, 8, 9, 10, 11, 12) . The proximal sequence element (PSE) is an essential promoter element
centered near position -55 and is required for accurate
initiation of snRNA transcription. The PSE is recognized by a
transcription factor variously named PSE binding
protein(13, 14) , PSE transcription factor (15) , or snRNA activating protein complex(16) . The
PSE binding factor is believed to play a role in recruiting the TATA
box-binding protein to snRNA
promoters(16, 17, 18, 19) . In
the chicken, there are two and only two genes that code for U4 snRNA (20, 21) . These genes, designated U4B and U4X, are
closely linked within 500 base pairs (bp) of each other in the chicken
genome. The two genes encode distinct sequence variants of U4 RNA that
differ at seven nucleotide positions. Moreover, the relative amount of
U4X and U4B RNA is differentially regulated during chicken development.
The U4X and U4B genes are expressed at nearly equal levels during early
embryogenesis, but U4X gene expression is specifically down-regulated
in a tissue-specific manner relative to U4B as development proceeds (22) . Although there is no direct evidence linking the
differential expression of the chicken U4X and U4B RNA genes to
transcriptional control, their promoter structures are consistent with
such a mechanism. First there is no obvious similarity between the U4B
and U4X gene 5`-flanking DNA other than the PSE and the enhancer
region. Second, both the enhancer and PSE contain a number of base
differences in crucial regulatory regions that could affect the
relative expression of the two U4 genes(20, 23) .
Third, just 5` of, and partially overlapping, the U4X PSE there exists
a unique dyad symmetry element that is not found in the U4B proximal
region. This palindromic sequence is recognized by a sequence-specific
DNA binding factor, proximal palindrome binding factor, whose DNA
binding activity is inversely related to the accumulation of U4X
RNA(23) . To gain further insight into the molecular basis
for the differential expression of the U4X and U4B genes, we have
generated constructs that possess chimeric U4B/U4X promoters, including
families of constructs with reciprocal point mutations in the PSE and
dyad symmetry elements. We find that the proximal regulatory region,
not the enhancer, is responsible for the differential activity of the
U4B and U4X genes in transient expression assays. Moreover, we identify
two specific nucleotide positions that differ between the U4X and U4B
PSEs that are crucial for U4 snRNA gene expression in these assays.
MATERIALS AND METHODS
Construction of PlasmidsAll constructs were in
the pUC19 vector. Plasmid BBB contained the chicken U4B gene, 280 bp of
5`-flanking DNA, and 283 bp of 3`-flanking DNA. Plasmid XXX contained
the U4X gene, 323 bp of 5`-flanking DNA, and 116 bp of 3`-flanking DNA.
These plasmids were previously designated pU4B(Sst) and pU4X(Sst) since
the cloned wild type fragments were flanked by natural SstI
sites(20) . Template BBX contained the U4B gene 5`-flanking DNA
but the coding region and 3`-flanking DNA of the U4X gene; it was
constructed by utilizing an AluI site that occurs at the
beginning of the U4 coding region. The reciprocal exchange of SstI-AluI fragments produced the template XXB.To
construct template BXX, U4B sequences from -227 to -142
were joined to position -132 of the U4X gene. Template -BX was
constructed by deleting U4B sequences from positions -280 to
-118 in the 5`-flanking region of the BBX construct. Template XBX
contained, in order, U4X sequences from -323 to -97, two
nucleotides (AT) of linker sequence, and U4B 5`-flanking DNA from
position -117 to the beginning of the gene, followed by the U4X
RNA coding region and 3`-flanking DNA. To construct the U4B
maxigene, 17 nucleotides from the pUC19 polylinker were inserted
between positions 8 and 9 of the U4B gene as follows. The construct
U4B -227 (9) was cut with EcoRI and HindIII, and the fragment containing the U4B gene sequence was
isolated. This fragment was then cut with restriction endonuclease FspI, giving blunt ends between nucleotides 8 and 9 of the U4B
DNA coding region. These fragments were then cloned between the EcoRI and SmaI sites and between the HindIII
and HincII sites of the pUC19 vector. Thus the plasmid
polylinker sequence between the HincII and SmaI sites
became a part of the U4B maxigene transcript. The U4mB/AS template was
constructed by exchanging the 5`-flanking DNA of U4mB with that of
U4B/AS(24) . The remaining U4X and U4B constructs that
contained point mutations were generated by site-directed mutagenesis
using polymerase chain reaction or by cloning synthetic
oligonucleotides between pre-existing restriction sites.
Expression Assays in Xenopus
OocytesMicroinjection of oocytes and analysis of labeled RNA
were performed as described previously(20) . Oocytes were each
injected with 30 nl of a solution containing 400 µg/ml U4
template DNA, 1 µg/ml Xenopus 5 S gene plasmid, and 8
µCi/ml [ - P]GTP. After an overnight
incubation, RNA was isolated from oocytes, analyzed by electrophoresis
in denaturing polyacrylamide gels, and autoradiographed. Normalization
for efficiency of injection and recovery of RNA was carried out by
adjusting the amounts of sample loaded in subsequent gels to give a
uniform 5 S RNA signal. Relative transcription efficiencies were
determined by cutting out the bands from the gels and quantitating in a
liquid scintillation counter.
Transfection of CV-1 CellsMonkey kidney CV-1
cells were grown in Dulbecco's modified Eagle's medium from
Life Technologies, Inc. supplemented with 5% bovine serum for
transfection experiments. Plates containing confluent cells were split
1:6 on 100-mm plates 24 h prior to transfection. Transfection was
carried out using the ProFection Mammalian Transfection System and
accompanying protocols from Promega. Each plate was transfected with 15
µg of the U4 plasmid DNA together with 5 µg of pcDNA3-CAT
plasmid (Invitrogen) as control for transfection efficiency. The cells
were exposed to the precipitate for 3 h after which the media was
replaced, and the cells were further incubated for 24 h before
harvesting. RNA from the transfected CV-1 cells was prepared using the
RNAgents Total RNA Isolation System employing guanidinium
isothiocyanate (Promega). U4 transcripts were measured by primer
extension as described below, and chloramphenicol acetyltransferase
transcripts were quantified by an RNase protection assay using a kit
purchased from Ambion (Austin, TX). Transfections were repeated a
minimum of three times and typical results are presented in the
figures.
Primer Extension AssaysAll primers were labeled
by phosphorylation with [ - P]ATP and T4
polynucleotide kinase. Primer extension of U4X RNA employed a labeled
U4X primer (5`-CCTCCGGGGAGGCTCTCAA-3`) that anneals specifically to U4X
RNA from position +123 to +141(22) . Primer extension
of U4maxiB RNA transcripts was performed with a ``maxi''
primer (5`-CTGCCACTGCGGGGATC-3`) that anneals specifically to U4maxiB
RNA from position +19 to +35.The primer extension
reactions were performed as follows: 5 ng of the specific primer
( 500,000 cpm) was mixed with 10 µg of total RNA in 10 µl
of 1 annealing buffer solution (250 mM KCl, 10 mM Tris-Cl, pH 8.3). The mixture was heated at 80 °C for 3 min
and transferred to a 45 °C water bath for 45 min. After 45 min of
annealing, 10 µl of ice-cold nuclease-free water was added to each
sample. To 10 µl of the annealed primer/RNA mixture, 12 µl of
reverse transcription mixture (24 mM Tris-Cl, pH 8.3, 16
mM MgCl , 0.8 mM each dNTP, 8 mM
dithiothreitol, 125 ng actinomycin D/µl, and 1.5 units of avian
myeloblastosis virus reverse transcriptase/µl) were added. This
mixture was incubated at 45 °C for 45 min to allow extension of the
primer. The reaction was stopped by adding 8 µl of stop solution
(100% formamide with 0.3% bromphenol blue and 0.3% xylene cyanol FF).
The samples were boiled for 3 min and then loaded on either a 20 or 10%
denaturing polyacrylamide gel for analysis of U4maxiB or U4X RNA,
respectively. The labeled bands were detected by autoradiography and
quantitated by PhosphorImager analysis.
RESULTS
Differential Activity of the U4B and U4X Genes Governed
by the Proximal Regulatory RegionWe previously observed that
the chicken U4B gene was efficiently transcribed from plasmids injected
into the nuclei of frog oocytes(20) . In contrast, the U4X gene
was not detectably expressed in the frog oocyte system(20) . To
localize the cis-acting sequences contributing to the differential
activity of the U4X and U4B genes in oocytes, chimeric constructs were
made by switching the proximal and/or enhancer region of the U4X gene
with the U4B gene proximal and/or enhancer region, respectively. A
schematic representation of these constructs is shown at the bottom of Fig. 1. The expression of each construct was assayed by
microinjection of the plasmids into frog oocytes together with
[ - P]GTP. The accumulation of chicken U4 RNA
was assayed by electrophoresis of the labeled RNA products in
denaturing polyacrylamide gels. The expression level of a co-injected 5
S RNA gene was used to normalize for the efficiency of the injection
into the oocyte nuclei. As noted previously(20) , the wild type
U4B gene was efficiently expressed in the oocyte assay, whereas the
wild type U4X gene was not detectably expressed (Fig. 1A,
lanes 2, 4, and 6). However, when the U4B gene
5`-flanking DNA was placed upstream of the U4X coding region, U4X RNA
was efficiently synthesized (BBX, lanes 1 and 9). In contrast, the U4X gene 5`-flanking DNA was unable to
drive efficient expression from the U4B coding region (XXB, lane 5). (An extremely low level of expression detectable from
this construct suggests that the U4B gene coding region or 3`-flanking
DNA makes a very minor contribution to the greater efficiency of U4B
gene expression. However, since expression of the construct was very
low, this observation has not been further investigated.)
Figure 1:
Transcriptional activities of chimeric
U4 gene constructs. A, chimeric constructs (diagrammed in C) were expressed by injection into the nuclei of Xenopus oocytes together with [ - P]GTP to label
the synthesized RNA. A 5 S RNA gene plasmid was coinjected to serve as
an internal control for injection efficiency and sample recovery. RNA
was isolated on the day following injection and aliquots were
electrophoresed through a denaturing polyacrylamide gel. Bands
corresponding to U4B or U4X RNA and to 5 S RNA are indicated. B, four of the chimeric constructs were transfected into CV-1
cells, total RNA was isolated, and the accumulation of U4X RNA was
assayed by primer extension using a primer specific for chicken U4X
RNA. The upper U4X band represents the full-length U4X
extension product, and the lower band corresponds to a shorter
product resulting from a strong stop for reverse
transcriptase(21) . C, a diagrammatic representation
of the chimeric U4 constructs is pictured to the left.
Relative expression levels in oocytes or in CV-1 cells is shown in the
corresponding columns to the right (nt, not tested). All
values are normalized to a U4XBX expression efficiency of
100%.
More
definitive conclusions were obtained from experiments employing the
chimeric constructs that combined the U4B enhancer with the U4X
proximal region, and vice versa. The U4B enhancer region was unable to
activate U4X gene expression from a template containing the U4X
proximal region (BXX, Fig. 1A, lane 3). In
contrast, the U4X enhancer fully supported a high level of
transcriptional activity from a template containing the U4B proximal
sequence (XBX, cf. lanes 8 and 9 versus lane 7).
Taken together, these results indicate that the U4X proximal region,
not the enhancer, is the regulatory region primarily responsible for
the inactivity of the U4X gene in frog oocytes. We next examined the
relative activities of the enhancer and proximal regions of the U4X and
U4B genes in a different expression system. Four of the chimeric
constructs that contain the U4X gene coding region were transfected
into monkey CV-1 cells, total RNA was prepared, and the accumulation of
U4X RNA was assayed by primer extension using a 17-mer primer
complementary to the 3` end of U4X RNA. This primer was chosen because
it does not cross-hybridize with any form of U4 RNA found in CV-1
cells(21, 22) . As shown in Fig. 1B,
the two constructs that contained the U4X proximal region, XXX and BXX,
were not detectably expressed (lanes 1 and 3). In
contrast, the two constructs that contained the U4B proximal region,
BBX and XBX, were efficiently expressed (lanes 2 and 4). Overall, the results in Fig. 1indicate that the
U4X proximal region is unable to support transcription in either frog
oocytes or monkey CV-1 cells, whereas the U4B gene proximal region is
an efficient promoter in both expression systems.
Base Alterations That Activate the U4X PSETo
further localize and identify the nucleotides responsible for the
differential activities of the U4X and U4B promoters, we introduced a
series of point mutations into the region near and within the U4X PSE
that, in a stepwise fashion, made the U4X PSE more similar to the U4B
PSE. The ability of these specific base alterations to rescue U4X
expression was measured by transient transfection of CV-1 cells. As
previously observed, a chimeric construct (XBX) that carried the wild
type U4B proximal region between the U4X enhancer and the U4X coding
region was efficiently expressed and served as the positive control in
this experiment (Fig. 2, lane 1). A 3 bp change in the
U4X PSE (at positions -49, -51, and -52) was not
sufficient to activate U4X expression (Fig. 2, lane 2).
The conversion of 8 additional bp between position -37 and
-48, bringing them into agreement with the U4B sequence, resulted
in a low level of U4X expression (lane 3). Interestingly,
nearly full activity was obtained from a construct in which the two
bases at positions -57 and -61 were changed to match the
U4B sequence (lane 4). These two changes not only increased
the similarity of the U4X PSE to the U4B PSE, but also destroyed the
perfect dyad symmetry of the palindromic sequence that overlaps the U4X
PSE. A marginal further increase in activity was observed from a
construct that combined the entire set of mutations extending from
-37 to -61 (lane 5). These results indicate that
the nucleotides at positions -57 and -61 play an especially
important role in determining the activities of the U4X and U4B
promoters in the transient expression assay. The downstream DNA
sequences in the 3` portion of the PSE (-37 to -52) appear
to make only a minor contribution toward the relative strengths of the
U4B and U4X promoters.
Figure 2:
Transcriptional activity of U4X gene
constructs with base substitutions in the proximal region. Following
transfection of CV-1 cells and isolation of total RNA, primer extension
analysis of U4X RNA was carried out as in Fig. 1B,
using the U4XBX construct as a positive control for normalization to
100% efficiency. The sequence alignment shows the point mutations that
were introduced into the PSE region of the U4X gene, gradually
converting it into identity with the U4B PSE. Dashes indicate
nucleotides identical to those in the wild type U4X sequence, whereas
differences are explicitly shown as lower case letters in the
mutant U4X constructs or as capital letters in the wild type
U4B proximal region sequence (bottom line). A 16-bp dyad symmetry
element (palindromic sequence) that overlaps the U4X PSE is underlined. Note that when the U4X and U4B PSE sequences are
aligned to maximize homology, the U4B PSE is two nucleotides closer to
the transcription start site. (The numbering above the
sequence alignment indicates U4X nucleotide positions, and the
numbering below is for U4B).
Reciprocal Base Alterations That Inactivate the U4B
PSETo further investigate and confirm the importance of the
bases at positions -61 and -57, we made the reciprocal
changes in the U4B PSE. However, it is important to note that, when the
U4X and U4B PSEs are aligned for maximum similarity, the U4B PSE is
located two nucleotides nearer to the transcription start site than the
U4X PSE. Thus positions -59 and -55 in the U4B PSE are the
counterparts of positions -61 and -57 in the U4X PSE (note
nucleotide numbering in Fig. 2). For the following studies, the
parent construct was U4mB/AS which contains 17 nucleotides from the
pUC19 polylinker inserted between positions 8 and 9 in the U4B coding
region. This allowed the resultant U4maxiB product to be distinguished
from the endogenous U4 RNA in primer extension assays. The U4mB/AS
construct also has two points mutations at positions -64 and
-48 that introduce ApaI and SstI sites,
respectively. These two point mutations have previously been shown to
have no detectable effect on the activity of the U4B gene in an oocyte
expression assay(24) .The U4mB/AS construct was efficiently
expressed in CV-1 cells (Fig. 3, lanes 1 and 7). However, a single C to T point mutation at position
-55 resulted in a 10-fold reduction in promoter activity (lane 2) and a single T to G change at position -59
resulted in a 6-fold reduction (lane 3). When the two point
mutations were combined (lane 4), the residual level of
expression was very low and was detectable only on long exposures or by
PhosphorImager analysis.
Figure 3:
Transcriptional activity of U4maxiB gene
constructs having mutations within or near the PSE. Total RNA was
prepared from transfected CV-1 cells and primer extension analysis was
carried out using a U4maxiB specific primer. The sequence alignment at
the bottom shows the alterations from the U4mB/AS sequence
shown in the top line. The underlined regions in the
U4mB/pal and U4mB/pal59 sequences indicate a 16-bp palindromic sequence
identical to that found upstream of the U4X PSE. Expression levels
relative to U4mB/AS (taken as 100%) are shown in the column to the right.
Role of the Palindromic SequenceWe next
investigated, in the context of the U4B promoter, the role of the
gene-specific dyad symmetry element that normally overlaps the U4X PSE.
Additional point mutations were introduced into the U4B proximal region
at positions -62, -66, and -70. This construct,
U4mB/pal, contains the entire 16-bp U4X palindromic sequence at a
position in the U4B promoter homologous to its location in the U4X
promoter. It overlaps the U4B PSE and includes the two strong
down-mutations at positions -55 and -59. When this
construct was transfected into CV-1 cells, there was no detectable
expression (Fig. 3, lanes 5 and 8). Restoring
the nucleotides at positions -55 and -59 back to the wild
type (which consequently also destroys the dyad symmetry element),
restored transcription to high levels (lanes 6 and 9).In an attempt to divorce the effect of the nucleotide
substitutions at positions -55 and -59 from potential
regulatory effects of the palindromic sequence, a construct was made in
which the palindrome was displaced 4 bp in the 5` direction. In this
construct (U4mB/pal59), the wild type U4B PSE sequence was maintained
to position -63, and the complete palindromic sequence extended
16 bp upstream beginning at position -59. Fig. 3, lane
10, shows that this construct was expressed at a wild type level
in CV-1 cells. Moreover, a construct that was mutated at six positions
within the palindromic sequence was expressed at a similar level (lane 11). Thus, expression of the U4B gene in CV-1 cells was
not significantly affected by either the presence or the absence of the
palindromic sequence near, but not extensively overlapping, the U4B
PSE.
DISCUSSION
We have investigated the cis-acting DNA sequences important
for the differential expression of the U4X and U4B genes in frog
oocytes and monkey CV-1 cells. The chicken U4B gene was efficiently
expressed in both oocytes and CV-1 cells, whereas the U4X gene was not
detectably expressed in either system. To localize the DNA sequences
responsible for this differential activity, enhancer and promoter swap
experiments were carried out using chimeric constructs. The results
indicated that the proximal region of the U4X gene was inactive in both
transient expression systems. To define the specific nucleotides
responsible for the difference in activity, point mutations were
introduced into the U4X proximal region to determine whether specific
changes (designed to match the sequence of the U4B PSE) could rescue
U4X expression. Indeed, the alteration of two nucleotides at positions
-57 and -61 was sufficient to raise the activity of the U4X
PSE to a level comparable to that of the U4B PSE (Fig. 2).
Moreover, some increased level of activity was alternatively obtained
by replacing the U4X sequences between -52 and -37 with the
corresponding nucleotides of the U4B PSE. These findings strongly
suggest that the U4X gene contains a suboptimal PSE sequence, and that
the nucleotides responsible for this effect are to some extent
delocalized throughout the PSE. However, it is clear that the greatest
down-effects on expression result from the presence of a G at position
-61 and a T at position -57. The importance of the bases
of these two positions was confirmed by making the reciprocal changes
at the homologous positions in the U4B PSE (positions -59 and
-55). These two nucleotide changes resulted in 10- and 6- fold
reductions in the U4B PSE activity, respectively, when the mutations
were assayed individually, and, when present together in the same
construct, resulted in essentially complete loss of activity (Fig. 3). It is perhaps significant that none of the other
cloned chicken U1, U2, or U4B genes contain either a G or a T at these
respective positions(20) . Our data localizing the critical
nucleotides to the proximal region are reminiscent of studies of
developmentally-regulated sea urchin U2 RNA genes performed by
Stefanovic and Marzluff(25) . In those studies, the sequences
responsible for the differential expression of the early and late U2
genes was localized to a 14-bp region within the U2 PSE. The two
critical nucleotide positions identified above are not only located
within the U4X PSE, but they also are members of a 16-bp dyad symmetry
element that overlaps the U4X PSE. Thus, in addition to disrupting DNA
recognition by the PSE-binding factor, mutations at these positions
could also affect DNA recognition by another factor, proximal
palindrome binding factor, that binds specifically to the palindromic
element(23) . In an attempt to separate and distinguish between
these two potential effects, a construct was prepared that contained an
intact palindromic sequence upstream of the U4B PSE (U4mB/pal59, Fig. 3). In this construct, the wild type U4B PSE was
maintained, but the palindromic sequence was displaced 4 bp upstream
relative to its homologous position in the wild type U4X proximal
region. As shown in Fig. 3, the palindromic sequence at this
position had no significant effect on expression of the U4mB
transcript. Thus, in this transient expression system, U4 gene
transcription was more closely correlated with the identities of the
nucleotides at U4B positions -59 and -55 (U4X positions
-61 and -57) rather than with the presence or the absence
of the intact palindromic sequence. Nonetheless, it remains a
possibility that the palindromic sequence in its natural chromosomal
context in chicken cells may play a role in regulating the
developmental expression of the U4X gene in vivo. Such effects
may not be observable in the heterologous transient expression systems
investigated here. Another possibility, not addressed by our
experiments, is that U4X gene activity conceivably could be regulated
in response to the methylation state of the multiple CpG dinucleotides
in the palindromic sequence (CGCGCCGGCGCG)(26) .
FOOTNOTES
- *
- This work was supported in part by the National
Institute of General Medical Sciences Grant GM33512 and in part by the
California Metabolic Research Foundation. The costs of publication of
this article were defrayed in part by the payment of page charges. This
article must therefore by hereby marked
``advertisement'' in accordance with 18 U.S.C.
Section 1734 solely to indicate this fact.
- §
- Recipient of an Arne N. Wick Predoctoral
Research Fellowship from the California Metabolic Research Foundation.
- ¶
- Present address: Dept. of Genetics, Faculty
of Life Sciences, Universiti Kebangsaan Malaysia, 43600 UKM Bangi,
Selangor DE, Malaysia.
- **
- To whom
correspondence should be addressed: Dept. of Chemistry, San Diego State
University, 5500 Campanile Dr., San Diego, CA 92182-1030. Tel.:
619-594-5575; Fax: 619-594-4634.
- (
) - The
abbreviations used are: snRNA, small nuclear RNA; PSE, proximal
sequence element; bp, base pair(s).
ACKNOWLEDGEMENTS
We thank Kathleen McNamara Schroeder for excellent
technical assistance, and Jon Miyake for many helpful discussions
throughout the course of this work.
REFERENCES
- Dahlberg, J. E., and Lund, E. (1988) in Structure and Function of Major and Minor Small Nuclear Ribonucleoprotein Particles (Birnstiel, M. L., ed) pp. 38-70, Springer Verlag KG, Heidelberg, Federal Republic of Germany
- Parry, H. D., Scherly, D., and Mattaj, I. W. (1989) Trends Biochem. Sci. 14, 15-19
- Reddy, R. and Singh, R. (1991) in Progress in Molecular and Subcellular Biology (Jeanteur, P., Kuchino, Y., Muller, W. E. G., and Paine, P. L., eds) pp. 1-36, Springer-Verlag, Berlin
- Hernandez, N. (1992) in Transcriptional Regulation (McKnight, S. L. and Yamamoto, K. R., eds) pp. 281-313, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
- Ares, M., Jr., Chung, J.-S., Giglio, L., and Weiner, A. M. (1987) Genes & Dev. 1, 808-817
- Janson, L., and Pettersson, U. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 4732-4736
[Abstract/Free Full Text]
- Roebuck, K. A., Walker, R. J., and Stumph, W. E. (1987) Mol. Cell. Biol. 7, 4185-4193
[Abstract/Free Full Text]
- Roebuck, K. A., Szeto, D. P., Green, K. P., Fan, Q. N., and Stumph, W. E. (1990) Mol. Cell. Biol. 10, 341-352
[Abstract/Free Full Text]
- Zamrod, Z., and Stumph, W. E. (1990) Nucleic Acids Res. 18, 7323-7330
[Abstract/Free Full Text]
- Cheung, C. H., Fan, Q. N., and Stumph, W. E. (1993) Nucleic Acids Res. 21, 281-287
[Abstract/Free Full Text]
- Ach, R. A., and Weiner, A. M. (1991) Nucleic Acids Res. 19, 4209-4218
[Abstract/Free Full Text]
- Weller, P., Bark, C., Janson, L., and Pettersson, U. (1988) Genes & Dev. 2, 1389-1399
- Waldschmidt, R., Wanandi, I., and Seifart, K. H. (1991) EMBO J. 10, 2595-2603
[Medline]
[Order article via Infotrieve]
- Wanandi, I., Waldschmidt, R., and Seifart, K. H. (1993) J. Biol. Chem. 268, 6629-6640
[Abstract/Free Full Text]
- Murphy, S., Yoon, J.-B., Gerster, T., and Roeder, R. G. (1992) Mol. Cell. Biol. 12, 3247-3261
[Abstract/Free Full Text]
- Sadowski, C. L., Henry, R. W., Lobo, S. M., and Hernandez, N. (1993) Genes & Dev. 7, 1535-1548
- Zamrod, Z., Tyree, C. M., Song, Y., and Stumph, W. E. (1993) Mol. Cell. Biol. 13, 5918-5927
[Abstract/Free Full Text]
- Yoon, J.-B., Murphy, S., Bai, L., Wang, Z., and Roeder, R. G. (1995) Mol. Cell. Biol. 15, 2019-2027
[Abstract]
- Henry, R. W., Sadowski, C. L., Kobayashi, R., and Hernandez, N. (1995) Nature 374, 653-656
[CrossRef][Medline]
[Order article via Infotrieve]
- Hoffman, M. L., Korf, G. M., McNamara, K. J., and Stumph, W. E. (1986) Mol. Cell. Biol. 6, 3910-3919
[Abstract/Free Full Text]
- McNamara, K. J., and Stumph, W. E. (1989) Nucleic Acids Res. 17, 6748
[Free Full Text]
- Korf, G. M., Botros, I. W., and Stumph, W. E. (1988) Mol. Cell. Biol. 8, 5566-5569
[Abstract/Free Full Text]
- Miyake, J. H., Botros, I. W., and Stumph, W. E. (1992) Gene Exp. 2, 161-173
- McNamara, K. J., and Stumph, W. E. (1990) J. Biol. Chem. 265, 9728-9731
[Abstract/Free Full Text]
- Stefanovic, B., and Marzluff, W. F. (1994) Gene Exp. 4, 1-18
- Cáceres, J. F., McKenzie, D., Thimmapaya, R., Lund, E., and Dahlberg, J. E. (1992) Nucleic Acids Res. 20, 4247-4254
[Abstract/Free Full Text]
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|